{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:46:42Z","timestamp":1758815202913,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.humimm.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T09:45:38Z","timestamp":1447494338000},"page":"146-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunosuppressive drugs affect induction of IFNy+ Treg in vitro"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-1031","authenticated-orcid":false,"given":"Volker","family":"Daniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-9114","authenticated-orcid":false,"given":"Karina","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Opelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.humimm.2015.11.006_b0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.trim.2012.08.003","article-title":"CD4(+)CD25(+)Foxp3(+)IFNgamma(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC","volume":"27","author":"Daniel","year":"2012","journal-title":"Transpl. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2015.11.006_b0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1432-2277.2008.00662.x","article-title":"Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome","volume":"21","author":"Daniel","year":"2008","journal-title":"Transpl. Int."},{"issue":"7","key":"10.1016\/j.humimm.2015.11.006_b0015","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2015.11.006_b0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2015.11.006_b0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humimm.2011.05.020","article-title":"CD4+CD25+Foxp3+IFN-gamma+ human induced T regulatory cells are induced by interferon-gamma and suppress alloresponses nonspecifically","volume":"72","author":"Daniel","year":"2011","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2015.11.006_b0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.humimm.2012.09.010","article-title":"CD4(+)CD25(+)Foxp3(+)IFNgamma(+)CD178(+) human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells","volume":"74","author":"Daniel","year":"2013","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2015.11.006_b0035","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1111\/ajt.12934","article-title":"Superiority of rapamycin over tacrolimus in preserving nonhuman primate treg half-life and phenotype after adoptive transfer","volume":"14","author":"Singh","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.humimm.2015.11.006_b0040","doi-asserted-by":"crossref","first-page":"e92888","DOI":"10.1371\/journal.pone.0092888","article-title":"Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation","volume":"9","author":"Satake","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.humimm.2015.11.006_b0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2013.11.018","article-title":"Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease","volume":"20","author":"Sugiyama","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.humimm.2015.11.006_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.humimm.2015.11.006_b0055","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/TP.0000000000000421","article-title":"CTLA4-Ig preserves thymus-derived T regulatory cells","volume":"98","author":"Ahmadi","year":"2014","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.humimm.2015.11.006_b0060","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.transproceed.2012.09.091","article-title":"Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil","volume":"44","author":"Miroux","year":"2012","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.humimm.2015.11.006_b0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08830185.2013.845181","article-title":"Interferon-gamma producing regulatory T cells as a diagnostic and therapeutic tool in organ transplantation","volume":"33","author":"Daniel","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.humimm.2015.11.006_b0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2172-13-47","article-title":"In-vitro inhibition of IFNgamma+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function","volume":"13","author":"Daniel","year":"2012","journal-title":"BMC Immunol."},{"issue":"11","key":"10.1016\/j.humimm.2015.11.006_b0075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/TP.0000000000000202","article-title":"High proportion of pretransplantation activated regulatory T cells (CD4+CD25highCD62L+CD45RO+) predicts acute rejection in kidney transplantation: results of a multicenter study","volume":"98","author":"San Segundo","year":"2014","journal-title":"Transplantation"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885915005595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T09:27:30Z","timestamp":1560504450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885915005595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0198885915005595"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2015.11.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive drugs affect induction of IFNy+ Treg in vitro","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}